Scientific article
English

The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone

Published inJournal of maternal-fetal & neonatal medicine, vol. 23, no. 9, p. 988-993
Publication date2010
Abstract

Recent data have raised concern about the safety of using misoprostol in women with preeclampsia. We wanted to evaluate the risk of placental abruption in women with preeclampsia undergoing cervical ripening with misoprostol compared to dinoprostone.

Keywords
  • Abruptio Placentae/epidemiology/etiology
  • Administration, Intravaginal
  • Adolescent
  • Adult
  • Cervical Ripening/drug effects
  • Dinoprostone/administration & dosage/adverse effects
  • Female
  • Humans
  • Incidence
  • Labor, Induced/methods
  • Middle Aged
  • Misoprostol/administration & dosage/adverse effects
  • Oxytocics/administration & dosage/adverse effects
  • Pre-Eclampsia/epidemiology/therapy
  • Pregnancy
  • Prostaglandins/administration & dosage/adverse effects
  • Risk
  • Young Adult
Citation (ISO format)
MARTINEZ DE TEJADA WEBER, Begona et al. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone. In: Journal of maternal-fetal & neonatal medicine, 2010, vol. 23, n° 9, p. 988–993. doi: 10.3109/14767050903443475
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1476-4954
704views
0downloads

Technical informations

Creation25/05/2012 10:57:00
First validation25/05/2012 10:57:00
Update14/03/2023 17:36:45
Status update14/03/2023 17:36:45
Last indexation29/10/2024 20:13:24
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack